About this trial
Chest wall tumors are one of the important diseases in thoracic surgery, and surgery remains the main method for treating this disease in clinical practice. The surgery for chest wall tumors requires extensive resection, and more importantly, precise resection. If the resection range is insufficient, it is easy to cause tumor recurrence and metastasis, which affects the patient's survival; If the resection range is too large, it will cause damage to the chest wall structure, affecting the patient's postoperative recovery and quality of life. At present, the determination of the surgical resection range mainly relies on the experience of the surgeon and the results of imaging examinations. Even if experienced surgeons still have multiple imaging examination results, there are still clinical difficulties of insufficient or excessive resection. Medical artificial intelligence is the in-depth application of artificial intelligence technology in the field of medicine. By processing and analyzing massive amounts of medical data, it can accurately locate tumors and optimize surgical plans. Therefore, it is proposed to compare the clinical effects of surgical resection of chest wall tumors using medical artificial intelligence algorithms and conventional imaging examination methods, in order to understand whether it can achieve more accurate tumor resection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients with benign or malignant chest wall tumors require surgical treatment ,meanwhile they have good overall condition and no signs of metastasis,
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Pathological results of surgical margins for chest wall tumors
Pathological diagnosis of residual tissue cells after tumor resection
Secondary outcomes
Surgical margins planned by medical artificial intelligence
Surgical resection edges and ranges delineated with the assistance of medical artificial intelligence algorithms
Surgical margins planned using conventional imaging techniques
The surgical resection edge and range delineated by conventional imaging examination methods
recurrence-free survival, RFS
The time from surgery to the earliest evidence of recurrence
Disease-free survival,DFS
The time at which the patient dies due to disease recurrence or progression after surgery
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: